Daniel Touchette
Full Professor, College of Pharmacy - Pharmacy Systems Outcomes and Policy
Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago
Director of Graduate Studies, Masters of Science in Comparative Effectiveness Research
Contact
Address:
833 S Wood St. MC 871, Chicago, Illinois
Office Phone:
Email:
Related Sites:
About Heading link
Research Interests:
My primary research interests are in the areas of pharmacoeconomics and comparative effectiveness research. I am particularly interested in evaluating innovative methods of delivering health care to complex patients with multiple chronic conditions to improve clinical outcomes and quality of life in an efficient manner. This includes, but is not limited to, the evaluation of clinical pharmacist and multidisciplinary activities such as medication therapy management and medical home models; development of programs to improve adherence to medications; and evaluation of pharmaceutical agents for efficiency and optimizing their use. Scientific methods employed in my research include cost-of-illness and cost-effectiveness analysis, pharmacoepidemiologic methods, and prospective comparative effectiveness trials.
Teaching and Supervision Heading link
Ph.D. Thesis Research (PSOP 599), 1/8/2024 – 4/26/2024
Independent Study (PSOP 596), 1/8/2024 – 4/26/2024
Comp Effectiveness Res Proj (PSOP 592), 1/8/2024 – 4/26/2024
Advanced Decision Analysis I (PSOP 580), 1/8/2024 – 4/26/2024
Concentration Research (PSOP 485), 8/21/2023 – 12/1/2023
CER Ethics and Privacy (PSOP 400), 8/21/2023 – 12/1/2023
Social and Behavioral Pharmacy (PHAR 462), 8/21/2023 – 10/27/2023
Social and Behavioral Pharmacy (PHAR 462), 8/21/2023 – 10/27/2023
Res in Pharm Syst Outcomes Pol (PSOP 380), 8/21/2023 – 12/1/2023
Selected Grants
Addressing Health-Related Social Needs in Pharmacy Setttings, UIC-OSF Community Health Advocacy Program., 1/1/2024 - 12/31/2024, Obligated Amount: $100000; No Anticipated Amount Set
Is a Medication Therapy Management program supported through 340B savings able to improve COVID vaccination rates among a vulnerable population?, 340B Health., 9/1/2022 - 4/1/2024, Obligated Amount: $7500; No Anticipated Amount Set
2022 - 2023 Institute for Clinical and Economic Review Consulting Agreement, Institute for Clinical and Economic Review., 1/1/2022 - 12/30/2025, Obligated Amount: $520000; Anticipated Amount: $520000
AbbVie Fellowship 2021-2023 - Dan Touchette and Mrinmayee Joshi, AbbVie, Inc.., 7/1/2021 - 6/30/2023, Obligated Amount: $201352; Anticipated Amount: $201352
Cost Effectiveness Analysis of Allogeneic Islet Cell Transplantation for Brittle Type 1 Diabetes, The Chicago Diabetes Project., 8/15/2020 - 7/31/2022, Obligated Amount: $40666; Anticipated Amount: $40666
2020 - 2021 Institute for Clinical and Economic Review Consulting Agreement, Institute for Clinical and Economic Review., 1/1/2020 - 12/31/2021, Obligated Amount: $425000; Anticipated Amount: $425000
An Etiology for Medication Ordering Errors in CPOE Systems, Washington University in St. Louis., 8/1/2018 - 7/31/2020, Obligated Amount: $56788; Anticipated Amount: $56788
Institute for Clinical and Economic Review consulting agreement for developing pharmacoeconomic models, Institute for Clinical and Economic Review (UIC contract #2017-001).., 6/30/2018 - 6/30/2019, Obligated Amount: $62500; No Anticipated Amount Set
An Etiology for Medication Ordering Errors in CPOE Systems, US Department of Health & Human Services (Agency for Healthcare Research & Quality)., 8/1/2017 - 7/31/2019, Obligated Amount: $142885; Anticipated Amount: $299999
Selected Publications
Lien, Pei-Wen, Joshi, Mrinmayee, Tice, Jeffrey A, Agboola, Foluso, Nikitin, Dmitriy, Withanawasam, Vinura, Jatoi, Saira, Touchette, Daniel R. (2024). Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.. Journal of Managed Care & Specialty Pharmacy, 30, (6), 517-527. doi:10.18553/jmcp.2024.30.6.517.
Choi, Sun A, Yan, Connie H, Gastala, Nicole M, Touchette, Daniel R, Stranges, Paul M. (2024). Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective. Journal of Substance Use and Addiction Treatment, 160, 209237. doi:10.1016/j.josat.2023.209237.
Caskey, RN, Joshi, M, Rasinski, K, Martin, MA, Munoz, GA, Kanabar, PN, Van Voorhees, BW, Touchette, DR. (2023). HSD131 Long-Term Impact of a Comprehensive Care Coordination Program on Medicaid Expenditures Among Children and Young Adults with Chronic Diseases. Value in Health, 26, (12), s319. doi:10.1016/j.jval.2023.09.1682.
POLLACK, MICHAEL, TKACZ, JOSEPH, SCHINKEL, JILL, LEWING, BENJAMIN, AGATEP, BARNABIE, SWISHER, SEAN, PATEL, SUSHMA, EDWARDS, DEVECHIO, TOUCHETTE, DANIEL, PORTILLO, EDWARD C, FEIGLER, NORBERT, STRANGE, CHARLIE. (2023). HEALTH CARE RESOURCE USE AND COSTS ASSOCIATED WITH PROMPT INITIATION OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AMONG PATIENTS WITH COPD: THE EROS STUDY. CHEST Journal, 164, (4), a4969-a4970. doi:10.1016/j.chest.2023.07.3218.
Huang, Hsiao‐Ching, Li, Wen‐Chin, Tadrous, Mina, Schumock, Glen T, Touchette, Daniel, Awadalla, Saria, Lee, Todd A. (2023). Evaluating the use of methods to mitigate bias from non‐transient medications in the case‐crossover design: A systematic review. Pharmacoepidemiology and Drug Safety, 32, (9), 939-950. doi:10.1002/pds.5649.
Joshi, M, Touchette, DR. (2023). EE383 Cost-Utility and Value of Information Analysis of Novel Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer. Value in Health, 26, (6), s129. doi:10.1016/j.jval.2023.03.684.
Joshi, Mrinmayee, Atlas, Steven J, Beinfeld, Molly, Chapman, Richard H, Rind, David M, Pearson, Steven D, Touchette, Daniel R. (2023). Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non–Muscle Invasive Bladder Cancer. Value in Health, 26, (6), 823-832. doi:10.1016/j.jval.2022.12.005.
Touchette, Daniel R, Perez, Alexandra. (2023). Improving the quality of economic evaluations of clinical pharmacy services. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 6, (6), 565-569. doi:10.1002/jac5.1776.
Deng, H, Gross, AE, Trotter, AB, Touchette, DR. (2023). EE477 Cost Evaluation of a Nurse Coordinated Outpatient Parenteral Antimicrobial Therapy (OPAT) Program. Value in Health, 26, (6), s146. doi:10.1016/j.jval.2023.03.778.
Professional Leadership
Associate Editor, BMC Health Services Research, 4/1/2018 - 8/31/2021
Education
Degrees:
Masters in Arts, Wayne State University, United States, 2000
Fellowship in Pharmacoeconomics and Outcomes Research, Wayne State University, United States, 1999
Doctor of Pharmacy, Wayne State University, United States, 1997
Bachelors of Science, University of Manitoba, Canada, 1991
Licensures and Certifications
Geriatric Pharmacy Update Certificate Course, University of Manitoba, Date Not Set - 1992
Current Issues in Chemical Dependency Certificate Course, University of Manitoba, Date Not Set - 1993
Graduate Summer Session in Epidemiology Certificate Program, University of Michigan–Ann Arbor, Date Not Set - 1998
Professional Licensure (Registered Pharmacist), State of Michigan, Date Not Set - Present